Stavros Georgiadis

Stavros Georgiadis

Stavros Georgiadis, CFA is an Equity Research Analyst and an Economist with an MSc in Applied Economics and Finance from Athens University of Economics and Business. He has been analyzing the global financial markets for two decades after getting his bachelor’s degree in Economics in 1997.

He received his CFA designation in 2016 and ever since has been working as a freelance financial analyst. He has his own financial website at https://www.thestockmarketontheinternet.com with the goal to start his own investment firm or investment fund and make it public on the U.S. stock exchange.

He has worked as an Economist and Operations Manager for a private shipping company for 15 years and has written various articles on investments, from stocks to cryptos. He focuses on the U.S. stock market and especially on stocks with great fundamentals, at an attractive valuation, and high-dividend stocks for income generation.

Stavros’ investment philosophy is to avoid all the noise on Wall Street and be very selective and picky applying a thorough fundamental analysis and due diligence. From a vast universe of stocks, only a few of them pass his own independent investment criteria. He is also a supporter of derivatives, mostly options as these can be used not just for speculation but to enhance financial returns in a portfolio.

He places a lot of importance on the fundamentals, but also believes that technical analysis can add supplementary value to investing in stocks.

Writing for InvestorPlace since 2020, he has written more than 150 articles for the website.

You can follow Stavros on LinkedIn and on Twitter.

Recent Articles

There’s More Bad News Than Good News Ahead for Workhorse Stock

Workhorse has a chance to disrupt the electric vehicle industry, but it requires tons of urgent improvements before WKHS stock is buy-worthy.

The 7 Best Startups You Can Buy on StartEngine Right Now

From blockchain and robotics to dog supplements and real estate, investors should consider these seven equity crowdfunding opportunities.

Novavax Is Selling a Dream, But You Should Live in Reality

The price of NVAX stock reflects hope in the company's Covid-19 vaccine, but hope doesn't change their poor fundamentals.

The Original BARK Company Loves Dogs, But Its Stock Is Hard to Like

BARK stock seems perfect for dog lovers, but it seems to be too early just yet to fall in love with the stock based on growth.

Fisker Is Still Too Risky Without Positive Free Cash Flow

FSR stock enjoyed a boost from both meme trading and the EV stock trend, but it needs to deliver real results before it becomes a buy.